share_log

Turning Point Therapeutics | SC14D9C: Written communication by the subject company relating to a third party tender offer

Turning Point Therapeutics | SC14D9C:报价书面通信

2022/06/03 17:18
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息